Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdulqader nashwan"'
Autor:
Mohammad Abu-Tineh, Awni Alshurafa, Elrazi Awadelkarim Hamid Ali, Yousef Hailan, Waail Rozi, Abdulqader nashwan, mohamed yassin, Ashraf Omer Elamin Ahmed, Khalid Mohamed Ibrahim Alhaj ALbsheer
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S15- (2021)
Objective: Following the launch of the TKI's (tyrosine kinase inhibitors) for the treatment of CML, establishing its significant control over the disease, other dimensions have emerged in regard to the safety of treatment, particularly the effect on
Externí odkaz:
https://doaj.org/article/bbe76b12b82c4a159b160c08c959f90f
Autor:
Abdulqader Nashwan, Waail Rozi, Mohammad Abu-Tineh, Mohamed A. Yassin, Awni Alshurafa, Elrazi Ali, Khalid Mohamed Ibrahim Alhaj ALbsheer, Yousef Hailan, Ashraf Ahmed
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S15-(2021)
Objective Following the launch of the TKI's (tyrosine kinase inhibitors) for the treatment of CML, establishing its significant control over the disease, other dimensions have emerged in regard to the safety of treatment, particularly the effect on M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff2ca4e307cc9208b2f031daea2dd18
http://www.sciencedirect.com/science/article/pii/S2531137921011160
http://www.sciencedirect.com/science/article/pii/S2531137921011160
Autor:
Dina S, Soliman, Einas, Al-Kuwari, Rajaa, Al-Abdulla, Prem, Chandra, Abdulqader, Nashwan, Feryal A, Hilmi
Publikováno v:
International journal of laboratory hematologyREFERENCES. 44(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9142d7f0d95f40d655fc638827d5eb20
https://pubmed.ncbi.nlm.nih.gov/34218524
https://pubmed.ncbi.nlm.nih.gov/34218524